Wyeth

Using data gleaned from business intelligence software, Wyeth is able to see demand for its products on a country-by-country basis and shift inventory to where it's needed. In the month leading up to the European launch of a treatment for rheumatoid arthritis and psoriatic arthritis, the company foresaw forecasted demand triple. The company's plants were able to respond successfully to the increased demand. Jeffrey B. Kindler, CEO of Pfizer and Bernard Poussot, CEO of Wyeth are shown here at a Jan. 26 news conference discussing the planned merger of their companies.